Susquehanna International Group, LLP Axonics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Axonics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 13,288 shares of AXNX stock, worth $943,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,288

Previous 10,239 29.78%

Holding current value

$943,182

Previous $688,000 34.45%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.3 - $69.67 $205,197 - $212,423	3,049 Added 29.78%	13,288 $925,000
Q2 2024 Aug 15, 2024	BUY	$66.47 - $69.65 $468,148 - $490,544	7,043 Added 220.37%	10,239 $688,000
Q1 2024 May 07, 2024	SELL	$56.67 - $69.36 $774,452 - $947,873	-13,666 Reduced 81.05%	3,196 $220,000
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $41,479 - $53,550	840 Added 5.24%	16,862 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $393,692 - $505,955	-8,094 Reduced 33.56%	16,022 $899,000
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $104,330 - $130,896	2,174 Added 9.91%	24,116 $1.22 Million
Q1 2023 May 16, 2023	BUY	$52.6 - $67.34 $641,351 - $821,076	12,193 Added 125.07%	21,942 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $1.21 Million - $1.56 Million	-20,342 Reduced 67.6%	9,749 $609,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $396,968 - $535,043	6,849 Added 29.47%	30,091 $2.12 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $506,982 - $826,830	-12,835 Reduced 35.58%	23,242 $1.32 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $647,833 - $929,538	14,811 Added 69.65%	36,077 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $227,595 - $333,815	4,551 Added 27.23%	21,266 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $1.62 Million - $2.16 Million	-27,444 Reduced 62.15%	16,715 $1.09 Million
Q2 2021 Aug 11, 2021	BUY	$51.39 - $66.9 $910,014 - $1.18 Million	17,708 Added 66.95%	44,159 $2.8 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $1.92 Million - $2.34 Million	-45,507 Reduced 63.24%	26,451 $1.32 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $2.32 Million - $3.36 Million	65,737 Added 1056.7%	71,958 $3.67 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $182,294 - $316,927	-7,957 Reduced 56.12%	6,221 $218,000
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $115,819 - $265,807	-7,045 Reduced 33.2%	14,178 $360,000
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $200,220 - $296,289	10,231 Added 93.08%	21,223 $588,000
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $132,069 - $208,063	4,906 Added 80.61%	10,992 $296,000
Q2 2019 Aug 16, 2019	BUY	$18.54 - $40.97 $112,834 - $249,343	6,086 New	6,086 $249,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Axonics, Inc. Transaction History